Xinhua News Agency, Jerusalem, July 22 (Reporter Shang Hao and Lu Yingxu) According to data released by the Israeli Ministry of Health on the 22nd, the effective rate of Pfizer's new crown vaccine in Israel to prevent new crown infection in Israel has dropped to 39 due to the influence of the mutated new crown virus delta strain.
According to the Israeli Ministry of Health, the relevant data was collected from June 20 to July 17
This result is quite different from the results of a British study published in the New England Journal of Medicine in the United States this week
Previous data from the Israeli Ministry of Health showed that from May 2 to June 5, the effective rate of Pfizer's vaccine in preventing new crown infections in Israel was 94.
Pfizer Pharmaceuticals' Phase III clinical trial data released in November last year showed that the effectiveness of Pfizer's vaccine to prevent new crown infections can reach 95%
The number of new confirmed cases of new crowns in Israel in a single day has dropped rapidly since April this year, once falling to single digits
The Israeli Prime Minister ’s Office issued a statement on the 22nd stating that the “green passport” policy will be restarted from the 29th in response to the new crown epidemic
Prime Minister Since Israel started receiving the new crown vaccine in December 2020, more than 5.
Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
